In search of a pan-coronavirus vaccine:next-generation vaccine design and immune mechanisms  

作　　者：S.Cankat M.U.Demael L.Swadling 

机构地区：[1]Division of Infection and Immunity,Institute of Immunity and Transplantation,University College London,Pears Building,London NW32PP,UK

出　　处：《Cellular & Molecular Immunology》2024年第2期103-118,共16页中国免疫学杂志（英文版）

基　　金：funded by a Rosetrees Trust and Pears Foundation Advancement Fellowship,SC is funded by a BBSRC LIDo-DTP PhD studentship(BB/T008709/1);UD is funded by an MRC DTP PhD studentship(MR/W006774/1);funding from the UCL Therapeutic.Acceleration Support scheme supported by funding from MRC IAA 2021 UCL MR/X502984/1.

摘　　要：Members of the coronaviridae family are endemic to human populations and have caused several epidemics and pandemics in recent history.In this review,we will discuss the feasibility of and progress toward the ultimate goal of creating a pan-coronavirus vaccine that can protect against infection and disease by all members of the coronavirus family.We will detail the unmet clinical need associated with the continued transmission of SARS-CoV-2,MERS-CoV and the four seasonal coronaviruses(HCoV-OC43,NL63,HKU1 and 229E)in humans and the potential for future zoonotic coronaviruses.We will highlight how first-generation SARS-CoV-2 vaccines and natural history studies have greatly increased our understanding of effective antiviral immunity to coronaviruses and have informed next-generation vaccine design.We will then consider the ideal properties of a pan-coronavirus vaccine and propose a blueprint for the type of immunity that may offer cross-protection.Finally,we will describe a subset of the diverse technologies and novel approaches being pursued with the goal of developing broadly or universally protective vaccines for coronaviruses.

关 键 词：VACCINE CORONAVIRUS Cross-reactive immunity CROSS-PROTECTION Universal 

分 类 号：R392[医药卫生—免疫学] R186[医药卫生—基础医学]